FMA Advisory’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $664K | Buy |
1,781
+3
| +0.2% | +$1.12K | 0.25% | 98 |
|
|
2021
Q2 | $679K | Sell |
1,778
-48
| -3% | -$18.3K | 0.25% | 90 |
|
|
2021
Q1 | $655K | Buy |
1,826
+3
| +0.2% | +$1.08K | 0.2% | 118 |
|
|
2020
Q4 | $585K | Buy |
1,823
+3
| +0.2% | +$963 | 0.2% | 122 |
|
|
2020
Q3 | $489K | Buy |
1,820
+4
| +0.2% | +$1.08K | 0.19% | 119 |
|
|
2020
Q2 | $478K | Buy |
1,816
+2
| +0.1% | +$526 | 0.21% | 112 |
|
|
2020
Q1 | $412K | Sell |
1,814
-2
| -0.1% | -$454 | 0.22% | 105 |
|
|
2019
Q4 | $549K | Buy |
1,816
+1
| +0.1% | +$302 | 0.22% | 109 |
|
|
2019
Q3 | $436K | Buy |
1,815
+1
| +0.1% | +$240 | 0.19% | 119 |
|
|
2019
Q2 | $512K | Sell |
1,814
-455
| -20% | -$128K | 0.23% | 110 |
|
|
2019
Q1 | $651K | Sell |
2,269
-248
| -10% | -$71.2K | 0.3% | 92 |
|
|
2018
Q4 | $661K | Sell |
2,517
-192
| -7% | -$50.4K | 0.34% | 82 |
|
|
2018
Q3 | $743K | Buy |
2,709
+5
| +0.2% | +$1.37K | 0.33% | 85 |
|
|
2018
Q2 | $644K | Buy |
2,704
+544
| +25% | +$130K | 0.3% | 91 |
|
|
2018
Q1 | $475K | Buy |
2,160
+3
| +0.1% | +$660 | 0.23% | 103 |
|
|
2017
Q4 | $485K | Buy |
2,157
+849
| +65% | +$191K | 0.23% | 107 |
|
|
2017
Q3 | $248K | Buy |
1,308
+1
| +0.1% | +$190 | 0.15% | 121 |
|
|
2017
Q2 | $245 | Sell |
1,307
-845
| -39% | -$158 | 0.13% | 102 |
|
|
2017
Q1 | $356K | Buy |
+2,152
| New | +$356K | 0.18% | 117 |
|
|
2015
Q2 | $423K | Buy |
+2,576
| New | +$423K | 0.26% | 87 |
|
|
2014
Q4 | $1.71M | Buy |
13,607
+61
| +0.5% | +$7.67K | 0.6% | 65 |
|
|
2014
Q3 | $1.62M | Sell |
13,546
-274
| -2% | -$32.8K | 0.6% | 66 |
|
|
2014
Q2 | $1.49M | Sell |
13,820
-33
| -0.2% | -$3.55K | 0.55% | 73 |
|
|
2014
Q1 | $1.38M | Buy |
13,853
+47
| +0.3% | +$4.68K | 0.54% | 74 |
|
|
2013
Q4 | $1.28M | Buy |
13,806
+188
| +1% | +$17.4K | 0.52% | 80 |
|
|
2013
Q3 | $1.14M | Buy |
13,618
+7
| +0.1% | +$585 | 0.45% | 80 |
|
|
2013
Q2 | $1.11M | Buy |
+13,611
| New | +$1.11M | 0.47% | 81 |
|